Search Results - "Olivera, M E"

Eudragit E100 as a Drug Carrier: The Remarkable Affinity of Phosphate Ester for Dimethylamine by Guzmán, M. L, Manzo, R. H, Olivera, M. E

“…Therapeutic agents containing phosphate groups in their molecules have increasing therapeutic impact. The object of this study was to characterize the cationic…”
Get full text

effect of weightbearing and limb load cycling on equine lamellar perfusion and energy metabolism measured using tissue microdialysis by Medina-Torres, C. E., Underwood, C., Pollitt, C. C., Castro-Olivera, E. M., Hodson, M. P., Richardson, D. W., van Eps, A. W.

“…REASONS FOR PERFORMING STUDY: Lamellar perfusion is thought to be affected by weightbearing and limb load cycling; this may be critical in the development of…”
Get full text

Microdialysis measurements of equine lamellar perfusion and energy metabolism in response to physical and pharmacological manipulations of blood flow by Medina-Torres, C. E., Underwood, C., Pollitt, C. C., Castro-Olivera, E. M., Hodson, M. P., Richardson, D. W., van Eps, A. W.

“…Summary Reasons for performing study A suitable method for evaluating lamellar perfusion changes and their metabolic consequences is currently lacking…”
Get full text

Biowaiver monographs for immediate release solid oral dosage forms: ciprofloxacin hydrochloride by Olivera, M E, Manzo, R H, Junginger, H E, Midha, K K, Shah, V P, Stavchansky, S, Dressman, J B, Barends, D M

“…Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of new multisource and reformulated…”
Get more information

Microdialysis measurements of lamellar perfusion and energy metabolism during the development of laminitis in the oligofructose model by Medina-Torres, C. E., Underwood, C., Pollitt, C. C., Castro-Olivera, E. M., Hodson, M. P., Richardson, D. W., van Eps, A. W.

“…REASONS FOR PERFORMING STUDY: Failure of lamellar energy metabolism, with or without ischaemia, may be important in the pathophysiology of sepsis‐associated…”
Get full text

Multinuclear solid state NMR investigation of two polymorphic forms of ciprofloxacin-saccharinate by Garro Linck, Y, Chattah, A K, Graf, R, Romañuk, C B, Olivera, M E, Manzo, R H, Monti, G A, Spiess, H W

“…Two polymorphic forms of a novel pharmaceutical compound, ciprofloxacin-saccharinate (CIP-SAC), are analyzed using one dimensional (1D) and two dimensional…”
Get more information

Crystallographic, thermal and spectroscopic characterization of a ciprofloxacin saccharinate polymorph by Romañuk, C.B., Garro Linck, Y., Chattah, A.K., Monti, G.A., Cuffini, S.L., Garland, M.T., Baggio, R., Manzo, R.H., Olivera, M.E.

“…A new polymorphic form of ciprofloxacin saccharinate (CIP-SAC II) is presented, and compared with CIP-SAC I, a different polymorph which we had previously…”
Get full text

Release kinetics and up-take studies of model fluoroquinolones from carbomer hydrogels by Vilches, A.P., Jimenez-Kairuz, A., Alovero, F., Olivera, M.E., Allemandi, D.A., Manzo, R.H.

“…Hydrogels of carbomer (C) loaded with model slightly soluble fluoroquinolone antimicrobials (AMFQ), norfloxacin (I) and ciprofloxacin (II) were prepared to…”
Get full text

Biowaiver monographs for immediate release solid oral dosage forms: amitriptyline hydrochloride by Manzo, R H, Olivera, M E, Amidon, G L, Shah, V P, Dressman, J B, Barends, D M

“…Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage…”
Get more information

The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case by Battistini, F.D., Tártara, L.I., Boiero, C., Guzmán, M.L., Luciani-Giaccobbe, L.C., Palma, S.D., Allemandi, D.A., Manzo, R.H., Olivera, M.E.

“…The aim of this work was to obtain information concerning the properties of ophthalmic formulations based on hyaluronic-drug ionic complexes, to identify the…”
Get full text

Reduced food interaction and enhanced gastrointestinal tolerability of a new system based on risedronate complexed with Eudragit E100: Mechanistic approaches from in vitro and in vivo studies by Guzman, M.L., Soria, E.A., Laino, C., Manzo, R.H., Olivera, M.E.

“…[Display omitted] Novel complexes consisting of Eudragit E100-risedronate are presented. The oral bioavailability of risedronate in rats was determined through…”
Get full text

Hyaluronan as drug carrier. The in vitro efficacy and selectivity of Hyaluronan–Doxorubicin complexes to affect the viability of overexpressing CD44 receptor cells by Battistini, F.D., Flores-Martin, J., Olivera, M.E., Genti-Raimondi, S., Manzo, R.H.

“…Schematic illustration of CD44-Hi-Dx complex. Mechanism implied in the enhanced internalization of Dx into cells. [Display omitted] We report Doxorubicin ionic…”
Get full text

Equine lamellar energy metabolism studied using tissue microdialysis by Medina-Torres, C.E., Pollitt, C.C., Underwood, C., Castro-Olivera, E.M., Collins, S.N., Allavena, R.E., Richardson, D.W., van Eps, A.W.

“…Failure of lamellar energy metabolism may contribute to the pathophysiology of equine laminitis. Tissue microdialysis has the potential to dynamically monitor…”
Get full text

Hospitalization and re-hospitalization of people with and without diabetes in La Plata, Argentina: comparison of their clinical characteristics and costs by Gagliardino, J.J, Martella, A, Etchegoyen, G.S, Caporale, J.E, Guidi, M.L, Olivera, E.M, González, C

“…Objective: To examine the prevalence, characteristics, and costs of hospitalization and re-hospitalization of diabetic and non-diabetic patients in La Plata,…”
Get full text

Costs of temporary and permanent disability induced by diabetes by OLIVERA, E. M, DUHALDE, E. P, GAGLIARDINO, J. J

“…Costs of temporary and permanent disability induced by diabetes. E M Olivera , E P Duhalde and J J Gagliardino Center for Experimental and Applied…”
Get full text

Enzymatic activity in the presence of surfactants commonly used in dissolution media, Part 1: Pepsin by Guzman, Maria L, Marques, Margareth R, Olivera ME, Maria E, Stippler, Erika S

“…The United States Pharmacopeia (USP) General Chapters Dissolution 〈711〉 and Disintegration and Dissolution of Dietary Supplements 〈2040〉 allows the use of…”
Get full text

A simple economic evaluation model for selecting diabetes health care strategies by Gagliardino, J J, Olivera, E M, Barragán, H, Puppo, R A

“…The aim of this work was to develop a simple model to evaluate the health care cost of diabetes in order to help decision-makers in selecting strategies for…”
Get more information

Characteristics, clinical course, and in-hospital mortality of non-insulin-dependent diabetic and nondiabetic patients with acute myocardial infarction in argentina by Gagliardino, Juan J., Werneke, Ursula, Olivera, Ercilia M., Assad, Daniel, Regueiro, Fernando, Diaz, Rafael, Pollola, Juan, Paolasso, Ernesto

“…The characteristics and clinical course of 1040 cases of acute myocardial infarction (AMI) among non-insulin-dependent diabetics (146) and nondiabetics (894)…”
Get full text

Monitorización de concentraciones plasmáticas de vancomicina en pacientes críticos de un hospital público de Córdoba, Argentina by Suarez, Maldonado, Vázquez, Olivera, ME

“…RESUMEN Introducción: La monitorización de las concentraciones plasmáticas de antimicrobianos utilizados para tratar infecciones en pacientes críticos es una…”
Get full text

Current situation of diabetic patients in hemodialysis in Buenos Aires by Olivera, E M, Elbert, A, Lercari, J M, Assad, D, Gagliardino, J J

“…The aim of this study was to evaluate the clinical and biochemical characteristics and the different types of treatment of diabetic patients in hemodialysis…”
Get more information